Imaging in neovascular age-related macular degeneration

Seminars in Ophthalmology

Volumn 26, Issue 3, 2011, Pages 225-233

  Gess, Adam J ^a   Fung, Anne E ^a,b   Rodriguez, Jorge G ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b Pacific Eye Associates   (United States)

Author keywords

age related macular degeneration; fluorescein angiography; fundus autofluorescence; imaging; indocyanine green angiography; optical coherence tomography

Indexed keywords

IODINE; LIPOFUSCIN; VERTEPORFIN;

ADVERSE OUTCOME; ANAPHYLAXIS; ANGIOGRAPHY; AUTOFLUORESCENCE; BRUCH MEMBRANE; CELL DEATH; CROSS ALLERGY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DRUSEN; EXUDATIVE MACULAR DEGENERATION; FLUORESCENCE ANGIOGRAPHY; FUNDUS AUTOFLUORESCENCE; HUMAN; HYPOTENSION; INDOCYANINE GREEN ANGIOGRAPHY; INTERMETHOD COMPARISON; NAUSEA; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PHOTORECEPTOR; PIGMENT EPITHELIUM; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA DETACHMENT; RETINA DISEASE; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RETINAL ANGIOMATOUS PROLIFERATION; REVIEW; SCANNING LASER OPHTHALMOSCOPE; SENSITIVITY AND SPECIFICITY; SKIN DISCOLORATION; SNEEZING; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; SYNCOPE; THICKNESS; TREATMENT CONTRAINDICATION; URTICARIA; VISUAL SYSTEM EXAMINATION; VOMITING;

DIAGNOSTIC IMAGING; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; MACULAR DEGENERATION;

EID: 79957590643     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2011.582533     Document Type: Review

References (36)

1. Macular Photocoagulations Study Group. Argon laser photocoagulation for senile macular degeneration. Arch Ophthalmol. 1982;100:912-23.
2. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Arch Ophthalmol. 1986;104:694-701.
3. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in agerelated macular degeneration with verteporfin: One-year results of 2 randomized clinical trials- TAP Report 1. Arch Ophthalmol. 1999;117:1329-45.
4. VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: twoyear results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. TAP and VIP Report no.
5. Am J Ophthalmol. 2001;31:540-560.
6. Zayit-Soudry S, Moroz I, Lowenstein A. Retinal pigment epithelial detachment. Surv Ophthalmol. 2007;52:227-243. (Pubitemid 46654138)
7. Gass JDM. Stereoscopic Atlas of Macular Disease: Diagnosis and Management, 4th ed. St. Louis: Mosby, 1997,24-6.
8. Bressler NM, Bressler SB, Fine SL. Neovascular (exudative) age-related macular degeneration. In: Ryan SJ, ed., Retina, 3rd ed. St. Louis: Mosby, 2001,1100-35.
9. Roquet W, Roudot-Thoraval F, Coscas G, et al. Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration. Br J Ophthalmol. 2004;88:638-42. (Pubitemid 38526646)
10. Berkow JW, Flower RW, et al. Fluorescein and Indocyanine Green Angiography Technique and Interpretation, 2nd ed. San Francisco, CA: American Academy of Ophthalmology, 1997.
11. Kwiterovich KA, Maguire MG, Murphy RP, et al. Frequency of adverse systemic reactions after fluorescein angiography: Results of a prospective study. Ophthalmology. 1991;98:1139-1142.
12. Brown DM and Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: Applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol. 2007;144:627-637.
13. Hubschman JP, Reddy S, Schwartz SD. Age related macular degeneration: Experimental and emerging treatments. Clinical Ophthalmology. 2009;3:167-174.
14. Kim SC, Lee SC, Seong YS, et al. Choroidal neovascularization characteristics and its size in optical coherence tomography. Yonsei Med J. 2003;44:821-827. (Pubitemid 37408076)
15. Sandhu SS, Talks SJ. Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosis choroidal neovascular membranes. Br J Ophthalmol. 2005;89:967-970. (Pubitemid 41081404)
16. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143:566-583.
17. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416-434. (Pubitemid 32971350)
18. Zweifel SA, Engelbert M, Laud K, et al. Outer retinal tubulation: A novel optical coherence tomography finding. Arch Ophthalmol. 2009;127(12):1596-1602.
19. Domalpally A, Danis RP, Zhang B, et al. Quality issues in interpretation of optical coherence tomograms in macular diseases. Retina. 2009;29:775-81.
20. Sandhu SS and Talks SJ. Correlation of optical coherence tomography with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes. Br J Ophthalmol. 2005;89:1184-1187.
21. Eter N, Spaide RF. Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photodynamic therapy. Retina. 2005;25:691-696. (Pubitemid 41254537)
22. Giani A, Cigada M, Choudhry N, et al. Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol. 2010;150(6):815-824.
23. Hassenstein A, Meyer CH. Clinical use and research applications of Heidelberg retinal angiography and spectraldomain optical coherence tomography: A review. Clin Exper Ophthalmol. 2009;37:130-143.
24. Yannuzzi LA, Ober MD, Slackter JS, et al. Ophthalmic fundus imaging: Today and beyond. Am J Ophthalmol. 2004;137:511-524. (Pubitemid 38328644)
25. Flower RW, Csaky KG, Murphy RP. Disparity between fundus camera and scanning laser ophthalmoscopic indocyanine green imaging of retinal pigment epithelial detachments. Retina. 1998;18:260.
26. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal vasculopathy (IPCV). Retina. 1990;10(1):1-8.
27. Sasahara M, Tsujikawa A, Musashi K, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeabilitiy. Am J Ophthalmol. 2006;142(4):601-7.
28. Hope-Ross, M, Yannuzzi LA, Gragoudas ES, et al. Adverse reactions due to indocyanine green. Ophthalmology. 1994;101:529-33. (Pubitemid 24100578)
29. Bonte CA, Ceuppens J, Leys AM. Hypotensive shock as a complication of indocyanine green injection. Retina. 1998;18:476-7. (Pubitemid 30387588)
30. Olsen TW, Lim JI, Capone A Jr, et al. Anaphylactic shock following indocyanine green angiography. Arch Ophthalmol. 1996;114:97. (Pubitemid 26026203)
31. Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: Indications and Interpretation. Ophthalmology. 2003;110:15-24.
32. Gaillard ER, Atherton SJ, Eldred G, et al. Photophysical studies on human retinal lipofuscin. Photochem Photobiol. 1995;61:448-453.
33. Schmitz-Valckenberg S, Holz FG, Bird AC, and Spaide RF. Fundus autofluorescence imaging. Retina. 2008;28:385-409.
34. Schmitz-Valckenberg S, Fleckenstein M, School HPN, and Holz FG. Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmology. 2009;54:96-117.
35. Dorey CK, Wu G, Ebenstein D, et al. Cell loss in the aging retina. Relationship to lipofuscin accumulations and macular degeneration. Invest Ophthalmol Vis Sci. 1989;30:1691-1699. (Pubitemid 19214989)
36. Holz FG, Bellman C, Staudt S, et al. Fundus autofluorescence and development of geographic atrophy in agerelated macular degeneration. Invest Ophthalmol Vis Sci. 2001;42:1051-1056. (Pubitemid 32289803)